A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer. [PDF]
Dig Dis Sci, 2022 Saller J +9 more
europepmc +1 more source
Thoracoscopic resection for esophageal cancer: A review of literature
Journal of Minimal Access Surgery, 2007 Esophageal resection remains the only curative option in high grade dysplasia of the Barrett esophagus and non metastasized esophageal cancer. In addition, it may also be an adequate treatment in selected cases of benign disease.
Scheepers Joris +3 more
doaj
Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection [PDF]
, 2017 Ceelen, Wim +6 more
core +1 more source
Effects of intraduodenally applied bile salts on pancreatic secretion [PDF]
, 1993 Lehnert, Peter, Riepl, Rudolf L.
core +1 more source
How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements. [PDF]
Qual Life Res, 2022 van der Ende-van Loon MCM +4 more
europepmc +1 more source
Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia [PDF]
, 1996 Drunen, E. (Ellen) van +5 more
core +1 more source
Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data. [PDF]
EClinicalMedicine, 2021 Swart N +6 more
europepmc +1 more source